Biotech RadarJobs updated

COMPANY

NanOlogy

HQ: Fort Worth, TX source · nanology.us ↗

Clinical Phase 2

Keywords: oncology solid tumors Urogenital Neoplasms Prostate Cancer Lung Cancer Diffuse Midline Glioma Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma Locally Advanced Pancreatic Carcinoma Nonsmall Cell Lung Cancer Small Cell Lung Cancer Neoplasm of Lung Locally Advanced Pancreatic Adenocarcinoma Bladder Cancer Urothelial Carcinoma Urinary Bladder Neoplasm Urinary Bladder Cancer Urologic Neoplasms Urologic Cancer Malignant Tumor of the Urinary Bladder Cancer of the Bladder Prostate Adenocarcinoma Prostate Cancer Adenocarcinoma Prostatic Neoplasm Male Genital Neoplasms Localized Cancer Cutaneous Metastasis Pancreatic Mucinous-Cystic Neoplasm Ovarian Carcinoma Renal Cell Carcinoma Kidney Cancer Adenocarcinoma of Kidney Renal Adenocarcinoma Renal Cell Cancer Adenocarcinoma of the Prostate NanoPac® LSAM-Cisplatin

Location: Fort Worth, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

12Trials (company is sponsor)

Timeline

  1. Trial start Phase 1/Phase 2: Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response source ↗
  2. Trial start Phase 2: Trial of NanoPac Intratumoral Injection in Lung Cancer source ↗
  3. Trial start Phase 2: Trial of NanoPac Focal Therapy for Prostate Cancer source ↗
  4. Trial start Phase 1: Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma source ↗
  5. Trial start Phase 1/Phase 2: Evaluation of NanoDoce® in Participants With Urothelial Carcinoma source ↗
  6. Trial start Phase 1/Phase 2: Study of Topical SOR007 Ointment for Cutaneous Metastases source ↗
  7. Trial start Phase 2: Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma source ↗
  8. Trial start Phase 2: Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms source ↗
  9. Trial start Phase 2: Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer source ↗
  10. Trial start II: Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 12

RecordTitlePhaseStatusStartPrimary completion
NCT07767110Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of ResponsePhase 1/Phase 2Not yet recruiting2026-122029-12 (estimated)
NCT03756311Expanded Access to NanoPacNot listedNo longer availableNot listedNot listed
NCT04060628Expanded Access to NanoDoceNot listedNo longer availableNot listedNot listed
NCT04314895Trial of NanoPac Intratumoral Injection in Lung CancerPhase 2CompletedApr 14, 2021Sep 26, 2023 (actual)
NCT03077685Trial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaPhase 2CompletedDec 1, 2017Mar 15, 2023 (actual)
NCT03636256Evaluation of NanoDoce® in Participants With Urothelial CarcinomaPhase 1/Phase 2CompletedApr 2, 2019Nov 2, 2021 (actual)
NCT04221828Trial of NanoPac Focal Therapy for Prostate CancerPhase 2TerminatedOct 20, 2020Jan 27, 2021 (actual)
NCT03101358Study of Topical SOR007 Ointment for Cutaneous MetastasesPhase 1/Phase 2CompletedJan 31, 2018Apr 29, 2020 (actual)
NCT03188991Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic NeoplasmsPhase 2CompletedSep 29, 2017Jun 29, 2020 (actual)
NCT03029585Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian CancerIITerminatedApr 19, 2017Nov 4, 2019 (actual)
NCT04260360Trial of NanoDoce Intratumoral Injection in Renal Cell CarcinomaPhase 1Withdrawn2020-042022-06 (estimated)
NCT03077659Trial of NanoPac® Focal Therapy in Subjects With Prostate CancerPhase 2CompletedSep 6, 2017Oct 4, 2018 (actual)
Feedback